Cleared Traditional

K973900 - TESTOTERONE ELISA

K973900 is an FDA 510(k) clearance for TESTOTERONE ELISA, manufactured by Kmi Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code CDZ cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K973900 · Kmi Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1998
Decision
133d
Days
Class 1
Risk

K973900 is an FDA 510(k) clearance for the TESTOTERONE ELISA. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Kmi Diagnostics, Inc. (Minneapolis, US). The FDA issued a Cleared decision on February 24, 1998 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Kmi Diagnostics, Inc. devices

FDA 510(k) Submission Details - K973900

510(k) Number K973900 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 14, 1997
Decision Date February 24, 1998
Days to Decision 133 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d slower than avg
Panel avg: 88d · This submission: 133d
Pathway characteristics
Predicate-based equivalence.

CDZ Device Classification - Class 1, General Controls

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 66
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K973900.
ACCESS TESTOSTERONE REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 33560, 33565
K001935 · Beckman Coulter, Inc. · Aug 2000
FREE TESTOSTERONE ENZYME IMMUNOASSAY, MODEL DSL-10-4900
K001086 · Diagnostic Systems Laboratories, Inc. · May 2000
ABBOTT ARCHITECT TESTOSTERONE
K983212 · Abbott Laboratories · Nov 1998
ACTIVE TESTOSTERONE EIA (DSL-10-4000)
K971823 · Diagnostic Systems Laboratories, Inc. · Jun 1997
ELECSYS TESTOSTERONE ASSAY
K964889 · Boehringer Mannheim Corp. · Mar 1997
TESTOSTERONEE ASSAY FOR THE TECHNICON IMMUNO 1 SYSTEM (IN-VITRO DIAGNOSTIC SYSTEM)
K963080 · Bayer Corp. · Sep 1996